Dr Andrew Francis Palmer, MD | |
310 Sunnyview Ln, Kalispell, MT 59901-3129 | |
(406) 752-5111 | |
Not Available |
Full Name | Dr Andrew Francis Palmer |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 20 Years |
Location | 310 Sunnyview Ln, Kalispell, Montana |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1023259215 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 17690 (Montana) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kalispell Regional Medical Center | Kalispell, MT | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Northern Rockies Anesthesia Consultants Pllc | 8022900208 | 29 |
Logan Health - Whitefish | 9335033687 | 43 |
News Archive
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.
Researchers have developed a small, flexible, elastic skeleton bound to two piezoelectric composites, which uses the electrical activity of the heart for power.
› Verified 2 days ago
Entity Name | Logan Health - Whitefish |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1396710851 PECOS PAC ID: 9335033687 Enrollment ID: O20040209001144 |
News Archive
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.
Researchers have developed a small, flexible, elastic skeleton bound to two piezoelectric composites, which uses the electrical activity of the heart for power.
› Verified 2 days ago
Entity Name | Northern Rockies Anesthesia Consultants Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912930199 PECOS PAC ID: 8022900208 Enrollment ID: O20040325000449 |
News Archive
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.
Researchers have developed a small, flexible, elastic skeleton bound to two piezoelectric composites, which uses the electrical activity of the heart for power.
› Verified 2 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Andrew Francis Palmer, MD 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 752-5111 | Dr Andrew Francis Palmer, MD 310 Sunnyview Ln, Kalispell, MT 59901-3129 Ph: (406) 752-5111 |
News Archive
The number of tumor cells circulating in the bloodstream of patients with metastatic, hormone-resistant, prostate cancer can predict how they will do with chemotherapy, according to results of an international trial.
The study, which assessed the clinical records of more than 17 million adults, also identified inequalities in the risk of needing admission to ICU and the risk of COVID-19-related death.
Scientists from Trinity College Dublin have developed a new gene therapy approach that offers promise for one day treating an eye disease that leads to a progressive loss of vision and affects thousands of people across the globe.
Researchers have developed a small, flexible, elastic skeleton bound to two piezoelectric composites, which uses the electrical activity of the heart for power.
› Verified 2 days ago
Kenyon W Kruse, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Dr. Katherine W Holley, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Dr. Melanie Pittard, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 425-407-1500 | |
Bradford L. Olson, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Michael A. Sugarman, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 | |
Kevin Jude Scholten, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 310 Sunnyview Ln, Kalispell, MT 59901 Phone: 406-752-5111 |